PRODUCT DESIGN CONFUSION

PRODUCT DESIGN CONFUSION was reported 103 times

These drug classes are most commonly taken by patients reporting PRODUCT DESIGN CONFUSION:

# Drug Count
0 GLP-1 Receptor Agonist [EPC] 18
1 Catecholamine [EPC] 4
2 Corticosteroid [EPC] 4
3 alpha-Adrenergic Agonist [EPC] 4
4 beta-Adrenergic Agonist [EPC] 4
5 Osmotic Laxative [EPC] 3
6 Potassium Salt [EPC] 3
7 Cardiac Glycoside [EPC] 2
8 Expectorant [EPC] 2
9 Histamine-2 Receptor Antagonist [EPC] 2
10 Proton Pump Inhibitor [EPC] 2
11 Serotonin-3 Receptor Antagonist [EPC] 2
12 alpha-1 Adrenergic Agonist [EPC] 2
13 Androgen Receptor Inhibitor [EPC] 1
14 Antifibrinolytic Agent [EPC] 1
15 Antihypoglycemic Agent [EPC] 1
16 Atypical Antipsychotic [EPC] 1
17 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1
18 Calcitonin [EPC] 1
19 Estrogen [EPC] 1
20 Folate Analog Metabolic Inhibitor [EPC] 1
21 Gastrointestinal Motility Inhibitor [EPC] 1
22 General Anesthetic [EPC] 1
23 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
24 Glycopeptide Antibacterial [EPC] 1
25 Histamine-1 Receptor Antagonist [EPC] 1
26 Insulin Analog [EPC] 1
27 Interferon beta [EPC] 1
28 Interleukin-23 Antagonist [EPC] 1
29 Interleukin-6 Receptor Antagonist [EPC] 1
30 Leukotriene Receptor Antagonist [EPC] 1
31 PCSK9 Inhibitor [EPC] 1
32 Prostacycline Vasodilator [EPC] 1
33 Radiographic Contrast Agent [EPC] 1
34 Serotonin Reuptake Inhibitor [EPC] 1
35 Sigma-1 Agonist [EPC] 1
36 Tumor Necrosis Factor Blocker [EPC] 1
37 Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] 1
38 Vitamin B12 [EPC] 1
39 Vitamin C [EPC] 1
40 Vitamin D [EPC] 1
41 alpha-Adrenergic Blocker [EPC] 1
42 beta3-Adrenergic Agonist [EPC] 1